Societe Generale Downgrades Merck & Co to Sell, Announces $104 Price Target
Portfolio Pulse from Benzinga Newsdesk
Societe Generale analyst Justin Smith downgraded Merck & Co (MRK) from Hold to Sell and set a price target of $104.

March 11, 2024 | 5:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck & Co was downgraded by Societe Generale from Hold to Sell with a new price target of $104.
The downgrade from Hold to Sell by a major financial institution like Societe Generale suggests a bearish outlook on Merck & Co's stock. This could lead to a negative short-term impact on its stock price, especially with the setting of a specific price target which might influence investor sentiment.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100